» Articles » PMID: 20516699

Protein Microarrays for Cancer Diagnostics and Therapy

Overview
Journal Med Princ Pract
Publisher Karger
Date 2010 Jun 3
PMID 20516699
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

In this postgenomic age, cancer will be understood in intricate detail beyond the genomic level. New technologies are emerging that allow global proteomic level characterization, profiling and understanding. One of the most exciting emerging technologies of cancer proteomics is protein microarray. In this review, the different types of protein microarrays are discussed, including the methods, challenges and techniques of each type. Subsequently, the application of these specific methods to cancer diagnosis, prognosis and therapy will be overviewed, providing a general review of current methods, and proposing how protein arrays will help shape the future of oncoproteomics.

Citing Articles

Novel Holistic Approaches for Overcoming Therapy Resistance in Pancreatic and Colon Cancers.

Sarkar F Med Princ Pract. 2015; 25 Suppl 2:3-10.

PMID: 26228733 PMC: 5588517. DOI: 10.1159/000435814.


Protein analytical assays for diagnosing, monitoring, and choosing treatment for cancer patients.

Powers A, Palecek S J Healthc Eng. 2014; 3(4):503-534.

PMID: 25147725 PMC: 4137876. DOI: 10.1260/2040-2295.3.4.503.


Proteomics for discovery of candidate colorectal cancer biomarkers.

Alvarez-Chaver P, Otero-Estevez O, Paez de la Cadena M, Rodriguez-Berrocal F, Martinez-Zorzano V World J Gastroenterol. 2014; 20(14):3804-24.

PMID: 24744574 PMC: 3983438. DOI: 10.3748/wjg.v20.i14.3804.


[Application of bio-chip in lung cancer research].

Zhu M, Yu J, Zhou W, Fu X Zhongguo Fei Ai Za Zhi. 2011; 14(5):441-5.

PMID: 21569652 PMC: 6000325. DOI: 10.3779/j.issn.1009-3419.2011.05.11.